Bookmark and Share

GlaxoSmithKline In Final Talks To Sell Locozade and Ribena

Japan’s Suntory Beverage & Food is in final round of talks with Britain’s leading drug maker, GlaxoSmithKline Plc. ADR (NYSE: GSK) to buy latter’s Locozade and Ribena drinks, said people familiar with the matter. These sources said that Suntory has offered more than 1 billion pounds (about $1.6 billion) to buy these brands. The deal is likely to be announced in coming days, sources said. The bid comes shortly after GlaxoSmithKline in April said that it intends to sell Lucozade and Ribena. Although these brands have been successful in Britain, they have struggled to gain foothold in international markets.


Leave a Reply

  

  

  

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>


-------------------------------------------------------------------------------------------------------------------------
All stories in DailyStocks.com are for informational purposes only. This is NOT a stock recommendation. This DailyStocks.com story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at DailyStocks.com . About Dailystocks.com: DailyStocks.com is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.